Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2014-11-18 GRAZIANO JAMES JOSEPH Chief Technology Officer Grant or award · Common Stock Option (right to buy) +28,140 28,140
2014-06-13 GRAZIANO JAMES JOSEPH Chief Technology Officer Returned to the company · Series FA Warrants −24,641 0
2014-06-13 GRAZIANO JAMES JOSEPH Chief Technology Officer Grant or award · Series FA Warrants +24,641 24,641
2014-05-16 GRAZIANO JAMES JOSEPH Chief Technology Officer Grant or award +104,386 104,386
2014-05-16 GRAZIANO JAMES JOSEPH Chief Technology Officer Grant or award · Warrant +24,641 24,641
2014-05-16 GRAZIANO JAMES JOSEPH Chief Technology Officer Grant or award · Warrant +807 807
2014-05-16 GRAZIANO JAMES JOSEPH Chief Technology Officer Grant or award · Warrant +27,211 27,211
2014-05-16 GRAZIANO JAMES JOSEPH Chief Technology Officer Grant or award · Warrant +76 76
2014-05-16 GRAZIANO JAMES JOSEPH Chief Technology Officer Grant or award · Warrant +1,361 1,361

Page 1 of 1 · 9 trades